98 related articles for article (PubMed ID: 31329685)
1. Correction: Sepers et al., "Endocannabinoid-Specific Impairment in Synaptic Plasticity in Striatum of Huntington's Disease Mouse Model".
J Neurosci; 2018 Aug; 38(33):7364. PubMed ID: 31329685
[TBL] [Abstract][Full Text] [Related]
2. Endocannabinoid-Specific Impairment in Synaptic Plasticity in Striatum of Huntington's Disease Mouse Model.
Sepers MD; Smith-Dijak A; LeDue J; Kolodziejczyk K; Mackie K; Raymond LA
J Neurosci; 2018 Jan; 38(3):544-554. PubMed ID: 29192125
[TBL] [Abstract][Full Text] [Related]
3. Correction: McNair et al. "A Role for RhoB in Synaptic Plasticity and the Regulation of Neuronal Morphology".
J Neurosci; 2017 Sep; 37(38):9346. PubMed ID: 31335926
[TBL] [Abstract][Full Text] [Related]
4. Correction: Araujo et al., "Foxp1 in Forebrain Pyramidal Neurons Controls Gene Expression Required for Spatial Learning and Synaptic Plasticity".
J Neurosci; 2018 Mar; 38(12):3147. PubMed ID: 31329677
[TBL] [Abstract][Full Text] [Related]
5. Correction: Emmons et al., "Rodent Medial Frontal Control of Temporal Processing in the Dorsomedial Striatum".
J Neurosci; 2018 May; 38(18):4456. PubMed ID: 31329682
[TBL] [Abstract][Full Text] [Related]
6. Erratum: Graber et al., "UPF1 Governs Synaptic Plasticity through Association with a STAU2 RNA Granule".
J Neurosci; 2017 Oct; 37(42):10253. PubMed ID: 31305598
[TBL] [Abstract][Full Text] [Related]
7. Correction: Henderson et al., Long-term Seizure Suppression and Optogenetic Analyses of Synaptic Connectivity in Epileptic Mice with Hippocampal Grafts of GABAergic Interneurons.
J Neurosci; 2016 May; 36(19):5427-5428. PubMed ID: 31265518
[TBL] [Abstract][Full Text] [Related]
8. Correction: Kiritani et al., Hierarchical Connectivity and Connection-Specific Dynamics in the Corticospinal-Corticostriatal Microcircuit in Mouse Motor Cortex.
J Neurosci; 2016 Sep; 36(37):9755. PubMed ID: 31335924
[TBL] [Abstract][Full Text] [Related]
9. Altered behavioral responses to gamma-aminobutyric acid pharmacological agents in a mouse model of Huntington's disease.
Hsu YT; Chang YG; Chang CP; Siew JJ; Chen HM; Tsai CH; Chern Y
Mov Disord; 2017 Nov; 32(11):1600-1609. PubMed ID: 28782830
[TBL] [Abstract][Full Text] [Related]
10. Correction: Babai et al., "Functional Roles of Complexin3 and Complexin4 at Mouse Photoreceptor Ribbon Synapses".
J Neurosci; 2017 Aug; 37(32):7796. PubMed ID: 31305591
[TBL] [Abstract][Full Text] [Related]
11. Compartmental loss of NADPH diaphorase in the neuropil of the human striatum in Huntington's disease.
Morton AJ; Nicholson LF; Faull RL
Neuroscience; 1993 Mar; 53(1):159-68. PubMed ID: 7682296
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid receptor messenger RNA levels decrease in a subset of neurons of the lateral striatum, cortex and hippocampus of transgenic Huntington's disease mice.
Denovan-Wright EM; Robertson HA
Neuroscience; 2000; 98(4):705-13. PubMed ID: 10891614
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation of synaptic proteins, dendritic spine abnormalities and pathological plasticity of synapses as experience-dependent mediators of cognitive and psychiatric symptoms in Huntington's disease.
Nithianantharajah J; Hannan AJ
Neuroscience; 2013 Oct; 251():66-74. PubMed ID: 22633949
[TBL] [Abstract][Full Text] [Related]
14. Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease.
Dowie MJ; Bradshaw HB; Howard ML; Nicholson LF; Faull RL; Hannan AJ; Glass M
Neuroscience; 2009 Sep; 163(1):456-65. PubMed ID: 19524019
[TBL] [Abstract][Full Text] [Related]
15. CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington's disease.
Boussicault L; Alves S; Lamazière A; Planques A; Heck N; Moumné L; Despres G; Bolte S; Hu A; Pagès C; Galvan L; Piguet F; Aubourg P; Cartier N; Caboche J; Betuing S
Brain; 2016 Mar; 139(Pt 3):953-70. PubMed ID: 26912634
[TBL] [Abstract][Full Text] [Related]
16. Changes in Dopamine Signalling Do Not Underlie Aberrant Hippocampal Plasticity in a Mouse Model of Huntington's Disease.
Dallérac GM; Cummings DM; Hirst MC; Milnerwood AJ; Murphy KP
Neuromolecular Med; 2016 Mar; 18(1):146-53. PubMed ID: 26782175
[TBL] [Abstract][Full Text] [Related]
17. Correction: Khemka et al., "Dissecting the Function of Hippocampal Oscillations in a Human Anxiety Model".
J Neurosci; 2018 Mar; 38(11):2899. PubMed ID: 31329676
[TBL] [Abstract][Full Text] [Related]
18. Comparison of phosphodiesterase 10A, dopamine receptors D1 and D2 and dopamine transporter ligand binding in the striatum of the R6/2 and BACHD mouse models of Huntington's disease.
Miller S; Hill Della Puppa G; Reidling J; Marcora E; Thompson LM; Treanor J
J Huntingtons Dis; 2014; 3(4):333-41. PubMed ID: 25575954
[TBL] [Abstract][Full Text] [Related]
19. It's not necessarily all about the delivery in Huntington's disease.
Parsons MP; Raymond LA
Neuron; 2014 Jul; 83(1):6-8. PubMed ID: 24991950
[TBL] [Abstract][Full Text] [Related]
20. Symptom-related changes of endocannabinoid and palmitoylethanolamide levels in brain areas of R6/2 mice, a transgenic model of Huntington's disease.
Bisogno T; Martire A; Petrosino S; Popoli P; Di Marzo V
Neurochem Int; 2008 Jan; 52(1-2):307-13. PubMed ID: 17664017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
